Neurology Research Review – Issue 71 – MS Special

March 8, 2021

The latest Neurology Research Review has been published with a special focus on Multiple Sclerosis. This issue is reviewed by Dr Jennifer Pereria, Specialist MS Neurologist at Auckland.

In this issue, researchers in Spain report that MS patients taking anti-CD20 treatments such as ocrelizumab and rituximab, might be at increased risk for COVID-19.

Download here

Other highlights include:

  • Trial reports positive results with  stem cell transplantation in patients with active and progressive MS
  • Is there an association between concussion in adolescence and future MS diagnosis?
  • Italian investigators suggest an association between lymphocyte count and dimethyl efficacy
  • Study finds that amantadine, modafinil and  methylphenidate do not improve fatigue associated with MS

This is a newsletter for health professionals. If you wish to be added to the database to receive this directly you can email Research Review Limited: ​or subscribe via their website directly

Back to top